Hartmut Riechers

Discovery and Optimization of a Novel Class of Orally Active Nonpeptidic Endothelin-A Receptor Antagonists

Hartmut Riechers, Hans-Peter Albrecht, Willi Amberg et al. · Journal of Medicinal Chemistry · 1996 · 119 citations · Full text

Medicinal Chemistry, Biochemistry, Functional Selectivity +14

Receptor Selectivity of Endothelin Antagonists and Prevention of Vasoconstriction and Endothelin-Induced Sudden Death

Manfred Raschack, Liliane Unger, Hartmut Riechers et al. · Journal of Cardiovascular Pharmacology · 1995 · 36 citations

Discovery and Synthesis of (<i>S</i>)-3-[2-(3,4-Dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic Acid (LU 302872), a Novel Orally Active Mixed ET_A/ET_B Receptor Antagonist

Willi M. Amberg, Stefan Hergenröder, Heinz Hillen et al. · Journal of Medicinal Chemistry · 1999 · 33 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Lu 302872 +13

Receptor Selectivity of Endothelin Antagonists and Prevention of Vasoconstriction and Endothelin-Induced Sudden Death

Manfred Raschack, Liliane Unger, Hartmut Riechers et al. · Journal of Cardiovascular Pharmacology · 1995 · 33 citations

New Endothelin, Cardiovascular Pharmacology, Pharmacotherapy +17

Structural Similarity and Its Surprises:  Endothelin Receptor Antagonists - Process Research and Development Report

Rolf Jansen, Michael Knopp, Willi M. Amberg et al. · Organic Process Research & Development · 2000 · 21 citations

Combinatorial Chemistry, Bioorganic Chemistry, Receptor Antagonists +20